As revealed by Wang et al., COL4A1 boosts proliferation, hepatocellular carcinoma (HCC) cell invasion and migration through the activation of FAK-Src pathway, which suggested that COL4A1 was the possible diagnostic and therapeutic marker for HCC (Wang et al., 2020b). This evidence concerns the gene PTK2 and hepatocellular carcinoma.